2026 NPPES data Vision Therapy Optometrist NPI 1922057306 O.D,P.A.
Verify on CMS →

CARL MCINNISH, O.D,P.A.

Vision Therapy Optometrist in BREWTON, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
109
Medicare Part D claims · 46 beneficiaries · Vision Therapy Optometrist avg: 209
Generic prescribing
42%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.6065/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$63.4
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: CARL MCINNISH, O.D,P.A. is a Vision Therapy Optometrist ([object Object]) practicing in BREWTON, Alabama with a Medicare Part D prescribing footprint of 109 claims across 46 beneficiaries — 58% brand-name prescribing . Their CMS MIPS Final Score of 93.6065/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $63.4 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: CARL MCINNISH, O.D,P.A. reported a CMS MIPS final score of 93.6065 out of 100, above the 83.1 national average, and filed 109 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

CARL MCINNISH, O.D,P.A. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 05/10/2006

NPI 1922057306

Primary specialty

Vision Therapy Optometrist

Rare

369 US NPIs in this specialty

Medicare Part D claims

109 48% vs specialty avg

2023 prescription claims

Specialty avg: 209

MIPS final score

93.6065/100 10.506500000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Alabama

How Vision Therapy Optometrist compares to other specialties among Alabama providers

Alabama providers

Vision Therapy Optometrist share within Alabama

1. Vision Therapy Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Vision Therapy Optometrist share within Alabama

Medicare quality performance — MIPS

CARL MCINNISH, O.D,P.A.'s 2023 MIPS final score plotted against the Vision Therapy Optometrist national average

High performer (top quartile)
MIPS Final Score
93.6065/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Vision Therapy Optometrist) — 93.6065/100 vs national avg 83.1

0%100%National avg83%93.6%
MIPS final score (Vision Therapy Optometrist) — 93.6065/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CARL MCINNISH, O.D,P.A. is a Vision Therapy Optometrist provider practicing in BREWTON, Alabama, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D,P.A.. NPI: 1922057306. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CARL MCINNISH, O.D,P.A. appears in the CMS NPPES registry as a Vision Therapy Optometrist provider holding O.D,P.A. credentials at 106 W JACKSON ST, BREWTON, AL, 36426, with a listed phone of (251) 867-3635. NPI 1922057306 was issued on 05/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCINNISH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 109 prescription claims written by this provider, covering 46 Medicare beneficiaries and totaling roughly $26K in drug spend, split 58% brand-name and 42% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.6065/100 for the 2023 performance year (Quality 99.8299), compared with the national average of 83.1.

Vision Therapy Optometrist is a narrow specialty nationwide, with 369 enrolled providers across 42 states and an average of 209 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

106 W JACKSON ST
BREWTON, AL 36426

Provider Details

NPI 1922057306
Specialty Vision Therapy Optometrist
Credentials O.D,P.A.
Gender Male
NPI Issued 05/10/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.6065
Final Score
Avg: 83.1
99.8299
Quality
79
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CARL MCINNISH, O.D,P.A.. Source: openpaymentsdata.cms.gov.

Total received

$63

Largest payer

Dompe US, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

CARL MCINNISH, O.D,P.A. — brand share 58.0%
Specialty average (est.)

58% brand-name claims vs 42% generic, on 109 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

109
Total Claims
$26K
Total Drug Cost
46
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
138
Total Day Supply
3,313
Brand vs Generic
58% brand / 42% generic
Brand Drug Cost
$24K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
74.8 years
Avg HCC Risk Score
0.87
Gender Split
65% female / 35% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
23
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
12
Restasis
Cyclosporine
11
Timolol Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Vision Therapy Optometrist Overview

How CARL MCINNISH, O.D,P.A. fits within the Vision Therapy Optometrist landscape nationally.

369
Vision Therapy Optometrist Providers in US
42
States with Vision Therapy Optometrist
209
Avg Claims per Provider

CARL MCINNISH, O.D,P.A.'s 109 claims are below the specialty average of 209.

Nearby Vision Therapy Optometrist Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as MCINNISH.

Compare Vision Therapy Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CARL MCINNISH, O.D,P.A.'s specialty?
CARL MCINNISH, O.D,P.A. specializes in Vision Therapy Optometrist and practices in BREWTON, Alabama. Credentials: O.D,P.A..
How much does CARL MCINNISH, O.D,P.A. prescribe under Medicare Part D?
In 2023, CARL MCINNISH, O.D,P.A. wrote 109 Medicare Part D claims totaling $26K in drug costs for 46 beneficiaries.
What is CARL MCINNISH, O.D,P.A.'s Medicare quality score?
CARL MCINNISH, O.D,P.A. has a CMS MIPS Final Score of 93.6065/100 (Quality: 99.8299). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CARL MCINNISH, O.D,P.A. located?
CARL MCINNISH, O.D,P.A. is located at 106 W JACKSON ST, BREWTON, AL, 36426. Phone: (251) 867-3635.
What is CARL MCINNISH, O.D,P.A.'s NPI number?
CARL MCINNISH, O.D,P.A.'s National Provider Identifier (NPI) is 1922057306, issued on 05/10/2006.
Does CARL MCINNISH, O.D,P.A. prescribe more brand-name or generic drugs?
CARL MCINNISH, O.D,P.A.'s prescribing is 58% brand-name and 42% generic drugs by claim count, with $24K in brand drug costs.
How many Vision Therapy Optometrist providers are there in the US?
There are 369 Vision Therapy Optometrist providers across 42 states in the US. The average Vision Therapy Optometrist provider writes 209 Medicare Part D claims per year.
What drugs does CARL MCINNISH, O.D,P.A. prescribe most often?
Based on 2023 Medicare Part D data, CARL MCINNISH, O.D,P.A.'s most frequently prescribed drugs include Latanoprost, Tobramycin-Dexamethasone, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CARL MCINNISH, O.D,P.A. accept Medicare?
CARL MCINNISH, O.D,P.A. appears in CMS Medicare data with 109 Part D claims and 46 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CARL MCINNISH, O.D,P.A.'s credentials?
CARL MCINNISH, O.D,P.A.'s NPI is 1922057306 with credentials O.D,P.A.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology